Evaluation of a decision aid and a personal risk profile in community pharmacy for patients considering options to improve cardiovascular health: the OPTIONS pilot study

Objective In a pilot study, to assess the feasibility and relevance of providing a community pharmacist consultation supplemented by a decision aid (DA) or a personal risk profile (PRP) to patients on lipid‐lowering or antihypertensive pharmacotherapy. Preliminary data on the clinical effectiveness of these interventions were collected.

[1]  Kate Lorig,et al.  Patients as partners in managing chronic disease , 2000, BMJ : British Medical Journal.

[2]  J. Prochaska,et al.  Transtheoretical therapy: Toward a more integrative model of change. , 1982 .

[3]  A. O'Connor.  Validation of a Decisional Conflict Scale , 1995, Medical decision making : an international journal of the Society for Medical Decision Making.

[4]  R. Thomson,et al.  Decision aids for people facing health treatment or screening decisions. , 2003, The Cochrane database of systematic reviews.

[5]  J. Kastelein,et al.  Declaring War on Undertreatment: Rationale for an Aggressive Approach to Lowering Cholesterol , 2002, Journal of cardiovascular risk.

[6]  K. Teo,et al.  Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP): A Randomized Trial Design of the Effect of a Community Pharmacist Intervention Program on Serum Cholesterol Risk , 1999, The Annals of pharmacotherapy.

[7]  K. Teo,et al.  A randomized trial of the effect of community pharmacist intervention on cholesterol risk management: the Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP). , 2002, Archives of internal medicine.

[8]  M. Abrahamowicz,et al.  Do doctors accurately assess coronary risk in their patients? Preliminary results of the coronary health assessment study , 1995, BMJ.

[9]  T. Pearson,et al.  The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals. , 2000, Archives of internal medicine.

[10]  E. Wagner,et al.  Care for chronic diseases , 2002, BMJ : British Medical Journal.

[11]  Peter Tugwell,et al.  Randomized Trial of a Portable, Self-administered Decision Aid for Postmenopausal Women Considering Long-term Preventive Hormone Therapy , 1998, Medical decision making : an international journal of the Society for Medical Decision Making.

[12]  J. Simons,et al.  Apparent discontinuation rates in patients prescribed lipid‐lowering drugs , 1996, The Medical journal of Australia.

[13]  V. Entwistle,et al.  Decision aids for people facing health treatment or screening decisions. , 2018, The Cochrane database of systematic reviews.

[14]  R. McPherson,et al.  Recommendations for the management of dyslipidemia and the prevention of cardiovascular disease: summary of the 2003 update. , 2003, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[15]  J. Frohlich,et al.  Recommendations for the management and treatment of dyslipidemia. Report of the Working Group on Hypercholesterolemia and Other Dyslipidemias. , 2000, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[16]  Thomas Bodenheimer,et al.  Improving primary care for patients with chronic illness. , 2002, JAMA.

[17]  Michael J Barry,et al.  Health Decision Aids To Facilitate Shared Decision Making in Office Practice , 2002, Annals of Internal Medicine.

[18]  T. Pearson.  The undertreatment of LDL-cholesterol: addressing the challenge. , 2000, International journal of cardiology.

[19]  M. Weinstein,et al.  Long-term persistence in use of statin therapy in elderly patients. , 2002, JAMA.

[20]  N. Campbell,et al.  Adherence to pharmacologic management of hypertension. , 1998, Canadian journal of public health = Revue canadienne de sante publique.

[21]  D. Tremblay,et al.  The effect of pharmacist intervention and patient education on lipid-lowering medication compliance and plasma cholesterol levels. , 2003, The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique.

[22]  M. Abrahamowicz,et al.  Can computerized risk profiles help patients improve their coronary risk? The results of the Coronary Health Assessment Study (CHAS). , 1998, Preventive medicine.

[23]  T. Bodenheimer,et al.  Patient self-management of chronic disease in primary care. , 2002, JAMA.

[24]  V. Entwistle,et al.  Decision aids for patients facing health treatment or screening decisions: systematic review , 1999, BMJ.

[25]  Elizabeth Drake,et al.  Development and Preliminary Testing of a Patient Decision Aid to Assist Pharmaceutical Care in the Prevention of Cardiovascular Disease , 2004, Pharmacotherapy.

[26]  J. Avorn,et al.  Persistence of use of lipid-lowering medications: a cross-national study. , 1998, JAMA.

[27]  G. L’italien,et al.  Distribution of blood pressure and hypertension in Canada and the United States. , 2001, American journal of hypertension.

[28]  D. D. de Ridder,et al.  Development, content, and process evaluation of a short self-management intervention in patients with chronic diseases requiring self-care behaviours. , 2003, Patient education and counseling.

[29]  M. Joffres,et al.  Awareness, treatment, and control of hypertension in Canada. , 1997, American journal of hypertension.

[30]  J. Dixon,et al.  Rethinking management of chronic diseases , 2004, BMJ : British Medical Journal.

[31]  Muhammad Mamdani,et al.  Adherence with statin therapy in elderly patients with and without acute coronary syndromes. , 2002, JAMA.

[32]  J O Prochaska,et al.  Strong and weak principles for progressing from precontemplation to action on the basis of twelve problem behaviors. , 1994, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.